21 bari 2023 English-speaking jobs in Liguria

recruiting for an Infrastructure Design Verification Project Manager - Maternity Leave to join its office in Bari

the role of non-coding RNAs in 3D chromatin Hubs” - Acronym : 3D-Hubs - Grant Agreement number : FIS-2023 ... (BANDO FIS 2)” - MACROSETTORE LS - Life Sciences, D.D. n. 1236 del 01 / 08 / 2023, within the “3D-Hubs ... SVILUPPO DELLE ATTIVITÀ DI RICERCA FONDAMENTALE, A VALERE SUL FONDO ITALIANO PER LA SCIENZA 2022 - 2023 ... of non-coding RNAs in 3D chromatin Hubs” project, Acronym : 3D-Hubs - Grant Agreement number : FIS-2023

the role of non-coding RNAs in 3D chromatin Hubs” – Acronym: 3D-Hubs – Grant Agreement number: FIS-2023 ... (BANDO FIS 2)” - MACROSETTORE LS - Life Sciences, D.D. n. 1236 del 01/08/2023, within the “3D-Hubs - ... SVILUPPO DELLE ATTIVITÀ DI RICERCA FONDAMENTALE, A VALERE SUL FONDO ITALIANO PER LA SCIENZA 2022 – 2023 ... role of non-coding RNAs in 3D chromatin Hubs” project, Acronym: 3D-Hubs – Grant Agreement number: FIS-2023

RINA is currently recruiting for a Cloud Architect to join its office in Genoa/Rome/Naples/Bari/Lecce

Postdoc Position at University of Florence Aug 31, 2023 The Department of Statistics, Computer Science

Location : Milano, Roma, Torino, Pisa, Napoli, Treviso, Cosenza, Genova, Bari, Salerno, Bologna.

Location : Milano, Roma, Torino, Pisa, Napoli, Treviso, Cosenza, Genova, Bari, Salerno, Bologna.

recognized as a great place to work by Great Place to Work in 2015, 2016, 2018, 2020, 2021, 2022, and 2023

recognized as a great place to work by Great Place to Work in 2015, 2016, 2018, 2020, 2021, 2022, and 2023

Why this could be the opportunity of a lifetime Rocket-ship growth: Replai ranks in Deloitte’s 2023-24

N.0000031.03-04-2023) #J-18808-Ljbffr

Contract type: Collective Bargaining Agreement (CCL) signed in 2020 and updated in 2023, fixed-term,

In 2023, we achieved revenues of approximately €33.6 billion.

With over 55 years of heritage, 340,000 team members across more than 50 countries, and 2023 revenues

Awards Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023

and as the World's Best Independent Hotel PMS Provider 2022 and 2023 by the World Travel Tech Awards ... achievements don't stop there; Mews was also listed among the World's Best Hotel PMS Provider 2023

Recognized as one of Fast Company's Most Innovative Companies in 2019, 2022, and 2023, and twice

Recognized as one of Fast Company's Most Innovative Companies in 2019, 2022, and 2023, and twice

After our successful Series D in 2021, we raised another $50M in 2023, doubling our valuation to $12B